作者: Kevin D. Lustig , Gary A. Weisman , John T. Turner , Richard Garrad , Andrew K. Shiau
DOI: 10.1002/9780470514900.CH11
关键词:
摘要: The cloning of a P2U purinoceptor cDNA has made it possible to use molecular biological approaches investigate function. Expression recombinant purinoceptors in mammalian cells lacking endogenous enabled us characterize the receptor protein and its downstream effectors, allowed partial analysis role certain amino acid residues ligand binding. These have placed pharmacological classification on firm footing generated model systems that can be used receptor-ligand binding, regulation signal transduction.